{"id":"W4323294773","doi":"10.2217/fon-2022-1059","title":"TRUST-II: a global phase II study of taletrectinib in <i>ROS1</i> -positive non-small-cell lung cancer and other solid tumors","year":2023,"lang":"en","type":"article","venue":"Future Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Crizotinib; ROS1; Medicine; Lung cancer; Internal medicine; Oncology; Cancer; Brain metastasis; Clinical trial; Interim analysis; Clinical endpoint; Adverse effect; Adenocarcinoma; Metastasis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009036444,0.0001585293,0.0004584593,0.0001121489,0.0001152384,0.000004043103,0.0000536164,0.0001149144,0.00008859535],"category_scores_gemma":[0.000009471501,0.0001281423,0.00004394662,0.0005052108,0.00005233266,0.00002985416,0.00007582227,0.000144411,0.000003436623],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003687603,"about_ca_system_score_gemma":0.0004005254,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001495835,"about_ca_topic_score_gemma":0.00412924,"domain_scores_codex":[0.9990245,0.0000454037,0.0002641527,0.000300058,0.0001086827,0.0002571683],"domain_scores_gemma":[0.9995396,0.00003732316,0.0001206128,0.0001439854,0.00006185094,0.00009658729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003814512,0.02421475,0.7433549,0.0004183714,0.001728231,0.002197044,0.1244693,0.000133739,0.005982711,0.0001902795,0.02519696,0.06829922],"study_design_scores_gemma":[0.1657129,0.0747557,0.5623519,0.0006617812,0.004105554,0.0003019623,0.0921715,0.001209598,0.003789404,0.00008254082,0.09392966,0.0009274471],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856531,0.0006182887,0.000002605959,0.001403869,0.0004937877,0.001223444,0.0001923472,0.00003779748,0.01037475],"genre_scores_gemma":[0.9969651,0.00007608483,0.00009014524,0.0007102417,0.0003652173,0.0002846941,0.00003039988,0.00001984728,0.001458261],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1810029,"threshold_uncertainty_score":0.5225491,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01232102561456113,"score_gpt":0.3856566028457878,"score_spread":0.3733355772312267,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}